LOWE CHRISTOPHER P. 4
4 · Cortexyme, Inc. · Filed Oct 7, 2021
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
LOWE CHRISTOPHER P.
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-10-05−4,963→ 95,037 totalExercise: $54.85Exp: 2030-02-05→ Common Stock (4,963 underlying) - Exercise/Conversion
Common Stock
2021-10-05$54.85/sh+4,963$272,221→ 64,963 total - Sale
Common Stock
2021-10-05$98.50/sh−4,963$488,856→ 60,000 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]1/48th of the shares subject to the option shall vest and become exercisable monthly over four years.